1.
Rationale and design for studies of renal denervation in the absence of antihypertensive medications
by Sanghvi, Kintur
The American heart journal, 2016-10-01, Vol.180, p.e1-e2
2.
Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy
by Hong, Song Hee
American journal of hypertension, 2013-07, Vol.26 (7), p.879-887
3.
Plasma Renin Activity Predicts Blood Pressure Responses to β-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension
by Turner, Stephen T
American journal of hypertension, 2010-09, Vol.23 (9), p.1014-1022
4.
Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients： A Population-based Longitudinal Cohort Study
by Chen, Hung-Yi
Chinese medical journal, 2016, Vol.129 (24), p.2907-2912
5.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proo...
by Townsend, Raymond R
The Lancet (British edition), 2017-11-11, Vol.390 (10108), p.2160-2170
6.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014-08-16, Vol.384 (9943), p.591-598
7.
Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey
by Su, Meng
The Lancet (British edition), 2017-12-09, Vol.390 (10112), p.2559-2568
8.
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Ang...
by Dahlöf, Björn
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.895-906
9.
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
by Tomaszewski, Maciej
Heart (British Cardiac Society), 2014-06, Vol.100 (11), p.855-861
10.
Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis
by Webb, Alastair JS, BMBCh
The Lancet (British edition), 2010, Vol.375 (9718), p.906-915
11.
Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised contro...
by Bath, PMW
The Lancet (British edition), 2015, Vol.385 (9968), p.617-628
12.
Initiation of antihypertensive therapy is associated with an increased risk of hip fracture
by Lönnroos, Eija
Aging health, 2013-04-01, Vol.9 (2), p.201-203
13.
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
by Elliott, William J, Prof
The Lancet (British edition), 2007, Vol.369 (9557), p.201-207
14.
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.375 (9718), p.938-948
15.
The double challenge of resistant hypertension and chronic kidney disease
by Rossignol, Patrick, Prof
The Lancet (British edition), 2015, Vol.386 (10003), p.1588-1598
16.
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
by Turnbull, Fiona
The Lancet (British edition), 2003-11-08, Vol.362 (9395), p.1527-1535
17.
Purinergic receptors in the carotid body as a new drug target for controlling hypertension
by Pijacka, Wioletta
Nature medicine, 2016-10, Vol.22 (10), p.1151-1159
18.
Sympathetic Neural Activity in Hypertension and Related Diseases
by Grassi, Guido
American journal of hypertension, 2010-10, Vol.23 (10), p.1052-1060
19.
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
by Copland, Emma
The lancet oncology, 2021-04, Vol.22 (4), p.558-570
20.
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
by Yusuf, S
The Lancet (British edition), 2009, Vol.373 (9672), p.1341-1351
